Mike Hixenbaugh
  Dr. Arturo Casadevall was working from home in Baltimore on Thursday when his phone started to buzz with messages from colleagues.
  The commissioner of the Food and Drug Administration had just announced during a White House press briefing that the agency was investigating the possibility of using  blood plasma donated by recovered coronavirus patients  as a promising short-term treatment for the virus.
  For weeks, Casadevall has led an ad hoc team of researchers from across the country who are working to establish a network of hospitals and blood banks that can begin collecting blood serum or plasma from coronavirus survivors, with the hopes of using it to treat critically ill patients and boost the immune systems of hospital workers.
  Read the full story here. 
 